Dmitry Kuzmin - Managing Partner @ 4BIO Capital

Overview

Number of Current Board & Advisor Roles

Number of Founded Organizations

Number of Partner Investments

Announced Date	Organization Name	Investor Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Hornet Therapeutics	4BIO Capital	Yes	Seed Round - Hornet Therapeutics	obfuscated obfuscation
obfuscated obfuscation	Ray Therapeutics	4BIO Capital	—	Series A - Ray Therapeutics	obfuscated obfuscation
obfuscated obfuscation	Araris Biotech	4BIO Capital	Yes	Series A - Araris Biotech	obfuscated obfuscation
obfuscated obfuscation	Code Biotherapeutics	4BIO Capital	—	Series A - Code Biotherapeutics	obfuscated obfuscation
obfuscated obfuscation	Ray Therapeutics	4BIO Capital	Yes	Seed Round - Ray Therapeutics	obfuscated obfuscation
obfuscated obfuscation	Code Biotherapeutics	4BIO Capital	Yes	Seed Round - Code Biotherapeutics	obfuscated obfuscation
obfuscated obfuscation	Redpin Therapeutics	4BIO Capital	Yes	Series A - Redpin Therapeutics	obfuscated obfuscation
obfuscated obfuscation	Orchard Therapeutics	4BIO Capital	—	Series B - Orchard Therapeutics	obfuscated obfuscation

Number of Current Jobs

Number of Past Jobs

has

current jobs as

Managing Partner

and

Postdoctoral Research Fellow

. Additionally,

has had

past job as the

Chief Scientific Officer

Organization Name	Title At Company	Start Date	End Date
RBV Capital	Chief Scientific Officer	Nov 2013	Nov 29, 2015

Number of Current Board & Advisor Roles

holds

board and advisor roles as

Board Member

and

Board Member

Hub Name	CB Rank (Hub)
London Investors with Funds Raised in 2022	52,512
London Seed Stage Investors	14,515
London Post IPO Investors	65,893
Genetics Companies With More Than 10 Employees	22,353
London Venture Capital Companies	24,191
United Kingdom Seed Stage Investors	9,870
England Post IPO Investors	65,892
England Investors with Funds Raised in 2019	22,585
Seed Stage Investors with Investments in England	4,491
England Late Stage Venture Investors	20,324